Search | Search by Center | Search by Source | Keywords in Title
Park JD, Mitra N, Asch DA. Public opinion about financial incentives for smoking cessation. Preventive medicine. 2012 Nov 1; 55 Suppl:S41-5.
OBJECTIVE: The aim of this study is to assess public support for a smoking cessation policy involving financial incentives. METHODS: We conducted a randomized controlled trial using an experimental survey design. One of four questionnaire versions was distributed to participants. Each version described a smoking cessation treatment costing $750 per success, including an unspecified treatment, medication, or financial incentive paid to the smoker. Participants indicated whether they would support a $25 increase in their annual health insurance premium to pay for the treatment. Questionnaires were distributed to adults waiting at public transportation depots in Philadelphia between May and August 2010. RESULTS: 1010 individuals completed the questionnaires about willingness to support the policy: 53% female, 27% African-American, 18% current smokers, and 46% with a household income below $40,000. The response rate was greater than 50%. Overall support for all smoking cessation treatments was 41.6%. The financial incentive version received the lowest support (39.3%) but that support did not statistically differ from the treatment (45.8%, p = 0.14) or medication (41.7%, p = 0.58) versions. CONCLUSIONS: Financial incentives were perceived no differently than currently used medications for smoking cessation. Most participants did not support any smoking cessation treatment options.